Bio was featured in Bankless on how AI is rewriting the DeSci equation.

Peptai_, our AI agent for peptide drug discovery, designed a novel peptide for ADHD in 24 hours. Wet lab validation of the peptide ran under $1,500. Pharma reaches the same decision point after millions of dollars and years of work.

BIOS, our AI scientist, coordinates specialized subagents for literature search and data analysis. Built to accelerate scientific discovery.

Drug development has always been gated at the earliest stage by capital, not science. Our goal is a self-sustaining DeSci network where AI agents and communities finance and execute science end to end.

Bio sits at the center of this shift.

Link to the article in the comments ↓